Fondaparinux Sodium 67457-0583-04
- Manufacturer
- Mylan Institutional Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 5, 2015
- Listing Expires
- December 31, 2026
- Application
- NDA021345
Need to source Fondaparinux Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fondaparinux Sodium | 5 mg/.4mL |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Selected Package
67457-0583-04Selected10 SYRINGE, GLASS in 1 CARTON (67457-583-04) / .4 mL in 1 SYRINGE, GLASS (67457-583-00)